Akero Therapeutics Cash from Operations (TTM) Insights

Akero Therapeutics Inc (AKRO)

20.71 -0.36 (-1.71%) USD | NASDAQ | May 16, 16:00

20.71 0.00 (0.00%) After-Hours: 20:00

Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 2018. Upgrade now.

Date	Value
March 31, 2024	-155.88M
December 31, 2023	-145.37M
September 30, 2023	-122.25M
June 30, 2023	-97.15M
March 31, 2023	-94.27M
December 31, 2022	-92.52M
September 30, 2022	-93.70M
June 30, 2022	-83.69M
March 31, 2022	-84.21M
December 31, 2021	-79.68M
September 30, 2021	-76.38M

Date	Value
June 30, 2021	-75.28M
March 31, 2021	-77.83M
December 31, 2020	-70.80M
September 30, 2020	-59.06M
June 30, 2020	-58.76M
March 31, 2020	-41.50M
December 31, 2019	-35.63M
September 30, 2019	-26.05M
June 30, 2019	-14.80M
March 31, 2019	-9.731M
December 31, 2018	-4.625M

Cash From Operations Definition

Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

-155.88M

Minimum

Mar 2024

-14.80M

Maximum

Jun 2019

-79.24M

Average

-78.76M

Median

Cash from Operations (TTM) Benchmarks